Fresenius SE & Co KGaA (FRE) Given a €85.00 Price Target by Commerzbank Analysts

Fresenius SE & Co KGaA (FRA:FRE) received a €85.00 ($101.19) price objective from Commerzbank in a note issued to investors on Wednesday. The brokerage currently has a “buy” rating on the stock. Commerzbank’s price target indicates a potential upside of 30.73% from the company’s current price.

Several other equities research analysts also recently commented on FRE. UBS Group set a €59.00 ($70.24) target price on shares of Fresenius SE & Co KGaA and gave the company a “sell” rating in a research note on Friday, January 5th. Warburg Research set a €80.00 ($95.24) target price on shares of Fresenius SE & Co KGaA and gave the company a “buy” rating in a research note on Tuesday, January 2nd. Independent Research set a €80.00 ($95.24) target price on shares of Fresenius SE & Co KGaA and gave the company a “buy” rating in a research note on Thursday, January 4th. Goldman Sachs Group set a €78.00 ($92.86) target price on shares of Fresenius SE & Co KGaA and gave the company a “neutral” rating in a research note on Tuesday, September 12th. Finally, Morgan Stanley set a €83.00 ($98.81) target price on shares of Fresenius SE & Co KGaA and gave the company a “buy” rating in a research note on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of €78.66 ($93.65).

Shares of Fresenius SE & Co KGaA (FRA FRE) opened at €65.02 ($77.40) on Wednesday. Fresenius SE & Co KGaA has a 12 month low of €60.16 ($71.62) and a 12 month high of €80.00 ($95.24). The company has a market cap of $35,910.00 and a P/E ratio of 20.71.

WARNING: “Fresenius SE & Co KGaA (FRE) Given a €85.00 Price Target by Commerzbank Analysts” was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://stocknewstimes.com/2018/01/12/fresenius-se-85-00-price-target-by-commerzbank-analysts.html.

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply